NEXMAB

Welcome to the Brand page for “NEXMAB”, which is offered here for Pharmaceuticals, monoclonal antibodies and fragments therefor for therapeutic purposes, the treatment and diagnosis of cancer, proliferative cell diseases, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases;pharmaceutical and biological product development for others relating to monoclonal antibodies; consultation in the field of pharmaceutical and biological product development relating to monoclonal antibodies;.

Its status is currently believed to be active. Its class is unavailable. “NEXMAB” is believed to be currently owned by “XENCOR, INC.”